Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
It's about managing the full picture
The Manufacturer Is Pushing Out Inventory In June, Dr
doi: 10.1016/j.mito.2013.01.008 15
This month, the Central Drugs Standard Control Organization (CDSCO) has approved Ranibizumab for the treatment of: Neovascular (Wet) Age-Related Macular Degeneration (AMD) Visual Impairment Due to Diabetic Macular Oedema (DME) As diabetes and age-related eye diseases continue to rise, innovations that help preserve vision are becoming more critical than ever
US$ 23.09
US$ 27.28
US$ 21.17
US$ 21.23
US$ 20.23
US$ 23.45
US$ 25.86
